OCCAM Immune is a not-for-profit Academic Research Organization (ARO) offering comprehensive immune monitoring services to support pharmaceutical and biotech companies conducting clinical trials. Founded by experts at Mount Sinai Hospital, we specialize in unique biomarker expertise and examining the immune system's response to new therapies across oncology, allergy, infectious diseases, and autoimmune disorders. At the heart of our innovation is Immune Monitoring as a Service (IMaaS), providing access to advanced technologies and standardized immune assays. These include Spectral Flow Cytometry immune phenotyping, Single-cell RNA sequencing, Spatial Transcriptomics, multiplex immunohistochemistry, antigen-specific T cell assays, seromics and antibody profiling, Luminex multiplex assays, Olink assays, and the automated ELLA system—all offered in a cost-effective manner. Additionally, OCCAM Immune ensures comprehensive and streamlined sample processing for patient specimens and biobanking with a Laboratory Information Management System (LIMS). Our approach delivers a detailed examination of the immune system's response to immunotherapy, enriched by expertise in single-cell omics analysis and antigen-specific assays, thus delivering unparalleled insights to our partners.

OCCAM Immune

Org chart

Teams

Offices